MCO
71
-7
CRM
60
-7
GILD
47
-8
SO
57
6
LH
40
-5
EL
15
-3
CMA
61
-3
PVH
60
-4
BEN
50
9
CNP
54
10
KHC
9
-4
TRIP
50
-4
MCD
52
-5
GE
61
-3
MO
60
-2
DRI
50
-3
CL
54
3
WYNN
36
-5
AIV
64
4
MLM
45
-5
MCO
71
-7
CRM
60
-7
GILD
47
-8
SO
57
6
LH
40
-5
EL
15
-3
CMA
61
-3
PVH
60
-4
BEN
50
9
CNP
54
10
KHC
9
-4
TRIP
50
-4
MCD
52
-5
GE
61
-3
MO
60
-2
DRI
50
-3
CL
54
3
WYNN
36
-5
AIV
64
4
MLM
45
-5
Financhill
Back

Atara Biotherapeutics 10K Form

Sell
48

ATRA
Atara Biotherapeutics

Last Price:
11.99
Seasonality Move:
37.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRA News And Ratings

See the #1 stock for the next 7 days that we like better than ATRA

ATRA Financial Statistics

Sales & Book Value

Annual Sales: $8.57M
Cash Flow: $-10.67M
Price / Cash Flow: 0
Annual Sales: $-22.61
Price / Book: 0

Profitability

EPS (TTM): -39.35000
Net Income (TTM): $-181.05M
Gross Margin: $-313K
Return on Equity: 0%
Return on Assets: -102.49%

Atara Biotherapeutics Earnings Forecast

Key Atara Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 6 years for ATRA is -3.65%.
  • The Selling, General & Administrative Expenses for ATRA have been equal to 593.82% of Gross Profit Margin.
  • The Research & Development expenses have been 2,622.01% of Revenue.
  • The Interest Expense is -1.91% of Operating Income.
  • The Net Earning history of ATRA is -3,220.88% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Atara Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATRA
CUSIP: 046513
Website: atarabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.42
Quick Ratio: 0.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRA Technical Analysis vs Fundamental Analysis

Sell
48
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy or a Sell?